[1. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHOEORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-85.10.1182/blood-2004-09-350215692063]Search in Google Scholar
[2. Gonzalez CL, Medeiros LJ, Braziel RM, Jaffe ES. T-cell lymphoma involving subcutaneous tissue: a clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol 1991; 15: 17-27.10.1097/00000478-199101000-000021985499]Search in Google Scholar
[3. Horvat M, Jezersek Novakovic B. Effect of response quality and line of treatment with rituximab on overall and disease-free survival of patients with B-cell lymphoma. Radiol Oncol 2010; 44: 232-8.10.2478/v10019-010-0044-6342370322933921]Search in Google Scholar
[4. Salhany KE, Macon WR, Choi JK, Elenitsas R, Lessin SR, Felgar RE, et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol 1998; 22: 881-93.10.1097/00000478-199807000-000109669350]Search in Google Scholar
[5. Paulli M, Berti E. Cutaneous T-cell lymphomas (including rare subtypes): current concepts II. Haematologica 2004; 89:1371-2.]Search in Google Scholar
[6. Willemze R, Jansen PM, Cerroni L, Berti E, Santucci M, Assaf C, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood 2008; 111: 838-45.10.1182/blood-2007-04-08728817934071]Search in Google Scholar
[7. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL: Harrison’s principles of internal medicine. New York: McGraw-Hill; 2005. p. 654.]Search in Google Scholar
[8. Weenig RH, Ng CS, Perniciaro C. Subcutaneous panniculitis-like T-cell lymphoma. Am J Dermatopathol 2001; 23: 206-15.10.1097/00000372-200106000-0000811391101]Search in Google Scholar
[9. Hoque SR, Child FJ, Whittaker SJ, Ferreira S, Orchard G, Jenner K, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients. Br J Dermatol 2003; 148: 516-25.10.1046/j.1365-2133.2003.05226.x12653744]Search in Google Scholar
[10. Marzano AV, Berti E, Paulli M, Caputo R. Cytophagocytic histiocytic panniculitis and subcutaneous panniculitis-like T-cell lymphoma. Arch Dermatol 2000; 136: 889-96.10.1001/archderm.136.7.88910890991]Search in Google Scholar
[11. Perniciaro C, Zalla MJ, White JW Jr, Menke DM. Subcutaneous T-cell lymphoma. Report of two additional cases and further observations. Arch Dermatol. 1993, 129: 1171-6.10.1001/archderm.129.9.11718363403]Search in Google Scholar
[12. Takeshita M, Imayama S, Oshiro Y, Kurihara K, Okamoto S, Matsuki Y, et al. Clinicopathologic analysis of 22 cases of subcutaneous panniculitis-like CD56- or CD56+ lymphoma and review of 44 other reported cases. Am J Clin Pathol 2004; 121: 408-16.10.1309/TYRGT196N2APLLR9]Search in Google Scholar
[13. Massone C, Chott A, Metze D, Kerl K, Citarella L, Vale E, et al. Subcutaneous, blastic natural killer (NK), NK/T-cell and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic and molecular study of 50 patients. Am J Surg Pathol 2004; 28: 719-35.10.1097/01.pas.0000126719.71954.4f15166664]Search in Google Scholar
[14. Lee HJ, Im JG, Goo JM, Kim KW, Choi BI, Chang KH, et al. Peripheral T-Cell lymphoma: spectrum of imaging findings with clinical and pathologic features. RadioGraphics 2003; 23: 7-26.10.1148/rg.23102501812533636]Search in Google Scholar
[15. Kang BS, Choi SH, Cha HJ, Jung YK, Lee JH, Jeong AK, et al. Subcutaneous panniculitis-like T-cell lymphoma: US and CT findings in three patients. Skeletal Radiol 2007; 36: S67-71.10.1007/s00256-006-0173-616909278]Search in Google Scholar
[16. Hodolic M. Role of 18F-choline PET/CT in evaluation of patients with prostate carcinoma. Radiol Oncol 2011; 45: 17-21.10.2478/v10019-010-0050-8342371422933929]Search in Google Scholar
[17. Huić D, Mutvar A, Kinda-Bašić S, Aurer T, Ciglar1M, Grošev D, et al. Negative predictive value of F-18-FDG coincidence PET in patients with Hodgkin’s disease and a residual mass after therapy: a retrospective diagnostic test study. Radiol Oncol 2009; 43: 258-63.10.2478/v10019-009-0024-x]Search in Google Scholar
[18. Jerusalem G, Hustinx R, Beguin Y, Fillet G. Evaluation of therapy for lymphoma. Semin Nucl Med 2005; 35: 186-96.10.1053/j.semnuclmed.2005.02.00416098292]Search in Google Scholar
[19. Ravizzini G, Meirelles GS, Horwitz SM, Grewal RK. F-18 FDG uptake in subcutaneous panniculitis-like T-cell lymphoma. Clin Nucl Med 2008; 33: 903-5.10.1097/RLU.0b013e31818bf2c719033805]Search in Google Scholar
[20. Kong EJ, Cho IH, Chun KA, Bae YK, Chol JH, Hyun MS. F-18 FDG PET/CT findings of subcutaneous panniculitis-like T-cell lymphoma: a case report. Nucl Med Mol Imaging 2009; 43: 240-4.]Search in Google Scholar
[21. Tsai EY, Taur A, Espinosa L, Quon A, Johnson D, Dick S, et al. Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography. Arch Dermatol 2006; 142: 577-84.10.1001/archderm.142.5.57716702495]Search in Google Scholar
[22. Kuo PH, McClennan BL, Carlson K, Wilson LD, Edelson RL, Heald PW, et al. FDG-PET/CT in the evaluation of cutaneous T-cell lymphoma. Mol Imaging Biol 2008; 10: 74-81.10.1007/s11307-007-0127-y18196347]Search in Google Scholar
[23. Rodriguez VR, Joshi A, Peng F, Rabah RM, Stockmann PT, Savaşan S. Positron emission tomography in subcutaneous panniculitis-like T-cell lymphoma. Pediatr Blood Cancer 2009; 52: 406-8.10.1002/pbc.2180518985722]Search in Google Scholar